Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

532
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
532
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

453
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
453
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

616
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
616
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

582
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
582
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

681
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
681
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

754
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
754

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TAVR in Patients With Prior Iliofemoral Stenting: Not All Stent Platforms Are Equal.

JACC. Cardiovascular interventions·2026
Same author

Open cavotomy for retrieval of inferior vena cava cement embolism after cement-augmented spinal fusion.

Journal of vascular surgery cases and innovative techniques·2026
Same author

Correction: Tortuosity in non-atherosclerotic vascular diseases is associated with age, arterial aneurysms, and hypertension.

Orphanet journal of rare diseases·2025
Same author

Shrink to Survive: Graft Design Influences Aneurysm Remodelling after Endovascular Aneurysm Repair.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025
Same author

Hydrogen sulfide aggravates neutrophil infiltration, vascular remodeling and elastase-induced abdominal aortic aneurysm in male mice.

Communications medicine·2025
Same author

Stimulating angiogenesis and post-ischemic tissue repair: Optimizing photobiomodulation parameters in vivo.

Journal of photochemistry and photobiology. B, Biology·2025

Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

4.8K

Abdominal Aortic Aneurysm: What About Screening?

Francois Saucy1, Sebastien Déglise, Thomas Holzer

  • 1Vascular Surgery Department, University Hospital, Rue du Bugnon 46, 1011 Lausanne, Switzerland. francois.saucy@chuv.ch.

Current Pharmaceutical Design
|August 27, 2015
PubMed
Summary

Screening for abdominal aortic aneurysm (AAA) is crucial due to its high mortality. This review examines AAA screening programs, focusing on benefits and drawbacks for targeted populations.

More Related Videos

Author Spotlight: Enhanced Murine AAA Model Using Elastase to Mimic Human Aneurysms
07:42

Author Spotlight: Enhanced Murine AAA Model Using Elastase to Mimic Human Aneurysms

Published on: July 26, 2024

3.1K
Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
09:32

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

Published on: February 23, 2020

6.9K

Related Experiment Videos

Last Updated: Apr 5, 2026

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

4.8K
Author Spotlight: Enhanced Murine AAA Model Using Elastase to Mimic Human Aneurysms
07:42

Author Spotlight: Enhanced Murine AAA Model Using Elastase to Mimic Human Aneurysms

Published on: July 26, 2024

3.1K
Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
09:32

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

Published on: February 23, 2020

6.9K

Area of Science:

  • Vascular Surgery
  • Public Health
  • Epidemiology

Background:

  • Abdominal aortic aneurysm (AAA) affects 4-9% of the general population.
  • Ruptured AAA carries a high mortality rate.
  • Screening programs aim to detect AAA early in at-risk individuals.

Purpose of the Study:

  • To review current literature on AAA screening.
  • To focus on epidemiology, screening tests, and evidence-based medicine.
  • To highlight the advantages and disadvantages of population-based AAA screening.

Main Methods:

  • Literature review of recent studies on AAA screening.
  • Analysis of epidemiological data related to AAA prevalence.
  • Evaluation of evidence supporting AAA screening programs.

Main Results:

  • AAA prevalence increases in individuals over 65 with a history of smoking.
  • Screening identifies both small and large AAA in selected patients.
  • Evidence supports the benefits and drawbacks of AAA screening.

Conclusions:

  • AAA screening programs are vital for early detection and improved outcomes.
  • Targeted screening in high-risk groups (e.g., older smokers) is recommended.
  • A balanced approach considering both benefits and limitations is essential for effective AAA screening strategies.